Does Motivation Matter? Analysis of a Randomized Trial of Proactive Outreach to VA Smokers

Elisheva R Danan, Anne M Joseph, Scott E Sherman, Diana J Burgess, Siamak Noorbaloochi, Barbara Clothier, Sandra J Japuntich, Brent C Taylor, Steven S Fu, Elisheva R Danan, Anne M Joseph, Scott E Sherman, Diana J Burgess, Siamak Noorbaloochi, Barbara Clothier, Sandra J Japuntich, Brent C Taylor, Steven S Fu

Abstract

Background: Current guidelines advise providers to assess smokers' readiness to quit, then offer cessation therapies to smokers planning to quit and motivational interventions to smokers not planning to quit.

Objectives: We examined the relationship between baseline stage of change (SOC), treatment utilization, and smoking cessation to determine whether the effect of a proactive smoking cessation intervention was dependent on smokers' level of motivation to quit.

Design: Secondary analysis of a multicenter randomized controlled trial.

Participants: A total of 3006 current smokers, aged 18-80 years, at four Veterans Affairs (VA) medical centers.

Interventions: Proactive care included proactive outreach (mailed invitation followed by telephone outreach), offer of smoking cessation services (telephone or face-to-face), and access to pharmacotherapy. Usual care participants had access to VA smoking cessation services and state telephone quitlines.

Main measures: Baseline SOC measured with Readiness to Quit Ladder, and 6-month prolonged abstinence self-reported at 1 year.

Key results: At baseline, 35.8 % of smokers were in preparation, 38.2 % in contemplation, and 26.0 % in precontemplation. The overall interaction between SOC and treatment arm was not statistically significant (p = 0.30). Among smokers in preparation, 21.1 % of proactive care participants achieved 6-month prolonged abstinence, compared to 13.1 % of usual care participants (OR, 1.8 [95 % CI, 1.2-2.6]). Similarly, proactive care increased abstinence among smokers in contemplation (11.0 % vs. 6.5 %; OR, 1.8 [95 % CI, 1.1-2.8]). Smokers in precontemplation quit smoking at similar rates (5.3 % vs. 5.6 %; OR, 0.9 [95 % CI, 0.5-1.9]). Within each stage, uptake of smoking cessation treatments increased with higher SOC and with proactive care as compared with usual care.

Limitations: Mostly male participants limits generalizability. Randomization was not stratified by SOC.

Conclusions: Proactive care increased treatment uptake compared to usual care across all SOC. Proactive care increased smoking cessation among smokers in preparation and contemplation but not in precontemplation. Proactively offering cessation therapies to smokers at all SOC will increase treatment utilization and population-level smoking cessation.

Trial registration: ClinicalTrials.gov NCT00608426.

Keywords: motivation; smoking cessation; veterans.

Figures

Figure 1
Figure 1
Engagement with smoking cessation therapies by baseline stage of change and treatment arm. PC = precontemplation, C = contemplation, P = preparation, ns = not significant, TC = telephone counseling, C&Rx = counseling & medication, VA Rx = VA-prescribed medication. * 95 % confidence interval for odds ratio does not contain 1.

References

    1. Centers for Disease Control and Prevention. Quitting smoking among adults—United States 2001–2010. 2011:1513–1519.
    1. Centers for Disease Control and Prevention. Current Cigarette Smoking Among Adults—United States, 2005–2013. 2014:1108–1112.
    1. Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2012;10
    1. Kotz D, Brown J, West R. ‘Real-world’ effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109(3):491–499. doi: 10.1111/add.12429.
    1. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34(2):102–111. doi: 10.1016/j.amepre.2007.09.033.
    1. Fiore M, Jaen C, Baker T, Bailey W, Benowitz N, Curry S, et al. Treating Tobacco use and Dependence: 2008 Update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008.
    1. Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychother Theory Res Pract Train. 1982;19:276–288. doi: 10.1037/h0088437.
    1. Spencer L, Pagell F, Hallion M, Adams T. Applying the transtheoretical model to tobacco cessation and prevention: a review of literature. Am J Health Promot. 2002;17(1):7–71. doi: 10.4278/0890-1171-17.1.7.
    1. Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010;11
    1. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–395. doi: 10.1037/0022-006X.51.3.390.
    1. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59(2):295–304. doi: 10.1037/0022-006X.59.2.295.
    1. Prochaska JO. Flaws in the theory or flaws in the study: a commentary on "the effect of transtheoretical model based interventions on smoking cessation". Soc Sci Med. 2009;68(3):404–406. doi: 10.1016/j.socscimed.2008.10.034.
    1. Velicer WF, Fava JL, Prochaska JO, Abrams DB, Emmons KM, Pierce JP. Distribution of smokers by stage in three representative samples. Prev Med. 1995;24(4):401–411. doi: 10.1006/pmed.1995.1065.
    1. Etter JF, Perneger TV, Ronchi A. Distributions of smokers by stage: international comparison and association with smoking prevalence. Prev Med. 1997;26(4):580–585. doi: 10.1006/pmed.1997.0179.
    1. Warner KE, Burns DM. Hardening and the hard-core smoker: concepts, evidence, and implications. Nicotine Tob Res. 2003;5(1):37–48. doi: 10.1080/1462220021000060428.
    1. Wewers ME, Stillman FA, Hartman AM, Shopland DR. Distribution of daily smokers by stage of change: current population survey results. Prev Med. 2003;36(6):710–720. doi: 10.1016/S0091-7435(03)00044-6.
    1. ITC Project. ITC United States National Report. Findings from the Wave 1 to 8 Surveys (2002–2011). Waterloo (ON): University of Waterloo; and Charleston (SC): Medical University of South Carolina: 2014.
    1. Lundahl BW, Kunz C, Brownell C, Tollefson D, Burke BL. A meta-analysis of motivational interviewing: twenty-five years of empirical studies. Res Soc Work Pract. 2010;20(2):137–160. doi: 10.1177/1049731509347850.
    1. Sciamanna C, Hoch J, Duke GC, Fogle M, Ford D. Comparison of five measures of motivation to quit smoking among a sample of hospitalized smokers. J Gen Intern Med. 2000;15(1):16–23. doi: 10.1046/j.1525-1497.2000.11198.x.
    1. Herzog TA, Abrams DB, Emmons KM, Linnan L. Predicting increases in readiness to quit smoking: a prospective analysis using the contemplation ladder. Psychol Health. 2000;15(3):369–381. doi: 10.1080/08870440008401999.
    1. Etter JF, Sutton S. Assessing ‘stage of change’ in current and former smokers. Addiction. 2002;97:1171–1182. doi: 10.1046/j.1360-0443.2002.00198.x.
    1. Herzog TA, Blagg CO. Are most precontemplators contemplating smoking cessation? Assessing the validity of the stages of change. Health Psychol. 2007;26(2):222–231. doi: 10.1037/0278-6133.26.2.222.
    1. Pisinger C, Vestbo J, Borch-Johnsen K, Jorgensen T. It is possible to help smokers in early motivational stages to quit. The Inter99 study. Prev Med. 2005;40(3):278–284.
    1. Tzelepis F, Paul CL, Walsh RA, Wiggers J, Duncan SL, Knight J. Predictors of abstinence among smokers recruited actively to quitline support. Addiction. 2013;108(1):181–185. doi: 10.1111/j.1360-0443.2012.03998.x.
    1. Curry S, McBride C, Grothaus L, Louie D, Wagner E. A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. J Consult Clin Psychol. 1995;63(6):1005–1014. doi: 10.1037/0022-006X.63.6.1005.
    1. West R. Time for a change: putting the transtheoretical (stages of change) model to rest. Addiction. 2005;100(8):1036–1039. doi: 10.1111/j.1360-0443.2005.01139.x.
    1. Kraft P, Sutton S, Reynolds H. The transtheoretical model of behavior change: are the stages qualitatively different? Psychol Health. 1999;14:433–450. doi: 10.1080/08870449908407339.
    1. Herzog TA. Analyzing the transtheoretical model using the framework of Weinstein, Rothman, and Sutton (1998): the example of smoking cessation. Health Psychol. 2008;27(5):548–556. doi: 10.1037/0278-6133.27.5.548.
    1. Hughes JR, Keely JP, Fagerstrom KO, Callas PW. Intentions to quit smoking change over short periods of time. Addict Behav. 2005;30(4):653–662. doi: 10.1016/j.addbeh.2004.08.011.
    1. Aveyard P, Begh R, Parsons A, West R. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012;107:1066–1073. doi: 10.1111/j.1360-0443.2011.03770.x.
    1. Fu SS, van Ryn M, Sherman SE. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial. JAMA Intern Med. 2014;174(5):671–677. doi: 10.1001/jamainternmed.2014.177.
    1. Fu SS, van Ryn M, Sherman SE, Burgess DJ, Noorbaloochi S, Clothier B, et al. Population-based tobacco treatment: study design of a randomized controlled trial. BMC Public Health. 2012;12:159. doi: 10.1186/1471-2458-12-159.
    1. Chabrol H, Niezborala M, Chastan E, de Leon J. Comparison of the heavy smoking index and of the fagerstrom test for nicotine dependence in a sample of 749 cigarette smokers. Addict Behav. 2005;30(7):1474–1477. doi: 10.1016/j.addbeh.2005.02.001.
    1. Abrams DB, Niaura R, Brown RA, Emmons KM, Goldstein MG, Monti PM. The Tobacco Dependence Treatment Handbook: A Guide to Best Practices. New York: The Guilford Press; 2003.
    1. Ibrahim J, Chen M, Lipsitz S. Missing responses in generalised linear mixed models when the missing data mechanism is nonignorable. Biometrika. 2001;88(2):551–564. doi: 10.1093/biomet/88.2.551.
    1. Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions. 3. New Jersey: Wiley; 2003.
    1. Tzelepis F, Paul CL, Walsh RA, McElduff P, Knight J. Proactive telephone counseling for smoking cessation: meta-analyses by recruitment channel and methodological quality. J Natl Cancer Inst. 2011;103(12):922–941. doi: 10.1093/jnci/djr169.
    1. Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011;106(12):2110–2121. doi: 10.1111/j.1360-0443.2011.03565.x.
    1. Hyland A, Borland R, Li Q, Yong HH, McNeill A, Fong GT, et al. Individual-level predictors of cessation behaviours among participants in the international tobacco control (ITC) four country survey. Tob Control. 2006;15(Suppl 3):iii83–iii94.
    1. Dijkstra A, De VH. Subtypes of precontemplating smokers defined by different long-term plans to change their smoking behavior. Health Educ Res. 2000;15(4):423–434. doi: 10.1093/her/15.4.423.
    1. Tzelepis F, Paul CL, Wiggers J, Walsh RA, Knight J, Duncan SL, et al. A randomised controlled trial of proactive telephone counselling on cold-called smokers' cessation rates. Tob Control. 2011;20(1):40–46. doi: 10.1136/tc.2010.035956.
    1. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2013;8
    1. Haas JS, Linder JA, Park ER. Proactive tobacco cessation outreach to smokers of low socioeconomic status: a randomized clinical trial. JAMA Intern Med. 2015;175(2):218–226. doi: 10.1001/jamainternmed.2014.6674.
    1. Pisinger C, Vestbo J, Borch-Johnsen K, Thomsen T, Jorgensen T. Acceptance of the smoking cessation intervention in a large population-based study: The Inter99 study. Scand J Public Health. 2005;33(2):138–145. doi: 10.1080/14034940410028370.
    1. Richter KP, Ellerbeck EF. It's time to change the default for tobacco treatment. Addiction. 2015;110(3):381–386. doi: 10.1111/add.12734.
    1. Brown C. Chaos and Catastrophic Theories: Quantitative Applications in the Social Sciences. London: Sage; 1995.
    1. West R, Sohal T. "Catastrophic" pathways to smoking cessation: findings from national survey. BMJ. 2006;332(7539):458–460. doi: 10.1136/.
    1. Carpenter MJ, Hughes JR, Gray KM, Wahlquist AE, Saladin ME, Alberg AJ. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011;171(21):1901–1907. doi: 10.1001/archinternmed.2011.492.
    1. Cropsey KL, Hendricks PS, Jardin B, Clark CB, Katiyar N, Willig J, et al. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38(10):2541–2546. doi: 10.1016/j.addbeh.2013.05.003.
    1. Jardin BF, Cropsey KL, Wahlquist AE, Gray KM, Silvestri GA, Cummings KM, et al. Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014;16(7):992–999. doi: 10.1093/ntr/ntu025.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj